Upcoming Dividend • Jun 11
Upcoming dividend of ₹12.00 per share Eligible shareholders must have bought the stock before 18 June 2026. Payment date: 25 July 2026. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 2.9%. Within top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.8%). Reported Earnings • May 06
Full year 2026 earnings: EPS misses analyst expectations Full year 2026 results: EPS: ₹50.17 (down from ₹65.50 in FY 2025). Revenue: ₹31.4b (down 1.4% from FY 2025). Net income: ₹4.72b (down 24% from FY 2025). Profit margin: 15% (down from 20% in FY 2025). The decrease in margin was primarily driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 11%. Revenue is forecast to grow 7.2% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Aankondiging • May 05
GHCL Limited, Annual General Meeting, Jun 25, 2026 GHCL Limited, Annual General Meeting, Jun 25, 2026. Aankondiging • Apr 08
GHCL Limited to Report Q4, 2026 Results on May 05, 2026 GHCL Limited announced that they will report Q4, 2026 results on May 05, 2026 Reported Earnings • Jan 30
Third quarter 2026 earnings released: EPS: ₹11.26 (vs ₹17.70 in 3Q 2025) Third quarter 2026 results: EPS: ₹11.26 (down from ₹17.70 in 3Q 2025). Revenue: ₹7.73b (flat on 3Q 2025). Net income: ₹1.06b (down 37% from 3Q 2025). Profit margin: 14% (down from 22% in 3Q 2025). Revenue is forecast to grow 8.0% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Aankondiging • Jan 07
GHCL Limited to Report Q3, 2026 Results on Jan 29, 2026 GHCL Limited announced that they will report Q3, 2026 results on Jan 29, 2026 Price Target Changed • Nov 15
Price target decreased by 8.5% to ₹751 Down from ₹820, the current price target is an average from 2 analysts. New target price is 24% above last closing price of ₹606. Stock is up 5.6% over the past year. The company is forecast to post earnings per share of ₹61.60 for next year compared to ₹65.50 last year. Reported Earnings • Nov 02
Second quarter 2026 earnings: EPS and revenues miss analyst expectations Second quarter 2026 results: EPS: ₹11.16 (down from ₹16.28 in 2Q 2025). Revenue: ₹7.38b (down 6.9% from 2Q 2025). Net income: ₹1.07b (down 31% from 2Q 2025). Profit margin: 14% (down from 20% in 2Q 2025). Revenue missed analyst estimates by 6.2%. Earnings per share (EPS) also missed analyst estimates by 23%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Aankondiging • Oct 29
GHCL Limited to Report Q2, 2026 Results on Nov 01, 2025 GHCL Limited announced that they will report Q2, 2026 results at 9:08 AM, Indian Standard Time on Nov 01, 2025 Reported Earnings • Aug 01
First quarter 2026 earnings: EPS in line with analyst expectations despite revenue beat First quarter 2026 results: EPS: ₹15.10 (down from ₹15.81 in 1Q 2025). Revenue: ₹8.23b (down 1.0% from 1Q 2025). Net income: ₹1.44b (down 4.3% from 1Q 2025). Profit margin: 18% (in line with 1Q 2025). Revenue exceeded analyst estimates by 3.0%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Upcoming Dividend • Jul 10
Upcoming dividend of ₹12.00 per share Eligible shareholders must have bought the stock before 17 July 2025. Payment date: 24 July 2025. Payout ratio is a comfortable 18% and this is well supported by cash flows. Trailing yield: 2.0%. Within top quartile of Indian dividend payers (1.2%). Higher than average of industry peers (0.7%). Aankondiging • Jul 02
GHCL Limited to Report Q1, 2026 Results on Jul 31, 2025 GHCL Limited announced that they will report Q1, 2026 results on Jul 31, 2025 Reported Earnings • Jun 26
Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2025 results: EPS: ₹65.50 (down from ₹83.43 in FY 2024). Revenue: ₹31.8b (down 7.6% from FY 2024). Net income: ₹6.24b (down 21% from FY 2024). Profit margin: 20% (down from 23% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) exceeded analyst estimates by 2.1%. Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Aankondiging • May 30
GHCL Limited announces Annual dividend, payable on July 24, 2025 GHCL Limited announced Annual dividend of INR 12.0000 per share payable on July 24, 2025, ex-date on July 17, 2025 and record date on July 17, 2025. Reported Earnings • May 10
Full year 2025 earnings: EPS in line with expectations, revenues disappoint Full year 2025 results: EPS: ₹65.50 (down from ₹83.43 in FY 2024). Revenue: ₹32.7b (down 5.1% from FY 2024). Net income: ₹6.24b (down 21% from FY 2024). Profit margin: 19% (down from 23% in FY 2024). Revenue missed analyst estimates by 2.2%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 7.8% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Aankondiging • May 08
GHCL Limited, Annual General Meeting, Jul 24, 2025 GHCL Limited, Annual General Meeting, Jul 24, 2025. Aankondiging • Apr 14
GHCL Limited to Report Fiscal Year 2025 Final Results on May 08, 2025 GHCL Limited announced that they will report fiscal year 2025 final results After-Market on May 08, 2025 Reported Earnings • Feb 01
Third quarter 2025 earnings released: EPS: ₹17.70 (vs ₹10.50 in 3Q 2024) Third quarter 2025 results: EPS: ₹17.70 (up from ₹10.50 in 3Q 2024). Revenue: ₹8.43b (up 5.7% from 3Q 2024). Net income: ₹1.68b (up 69% from 3Q 2024). Profit margin: 20% (up from 13% in 3Q 2024). The increase in margin was primarily driven by higher revenue. Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings. Aankondiging • Jan 14
GHCL Limited to Report Q3, 2025 Results on Jan 31, 2025 GHCL Limited announced that they will report Q3, 2025 results on Jan 31, 2025 Recent Insider Transactions • Dec 17
Insider recently sold ₹2.2m worth of stock On the 12th of December, Bhuwneshwar Mishra sold around 3k shares on-market at roughly ₹739 per share. This transaction amounted to 8.6% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought ₹2.2m more than they sold in the last 12 months. Valuation Update With 7 Day Price Move • Dec 12
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹740, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 145% over the past three years. Reported Earnings • Oct 30
Second quarter 2025 earnings released: EPS: ₹16.28 (vs ₹15.01 in 2Q 2024) Second quarter 2025 results: EPS: ₹16.28 (up from ₹15.01 in 2Q 2024). Revenue: ₹8.10b (flat on 2Q 2024). Net income: ₹1.55b (up 8.4% from 2Q 2024). Profit margin: 19% (up from 18% in 2Q 2024). Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 13% per year, which means it is tracking significantly ahead of earnings growth. Aankondiging • Oct 04
GHCL Limited to Report Q2, 2025 Results on Oct 29, 2024 GHCL Limited announced that they will report Q2, 2025 results on Oct 29, 2024 Reported Earnings • Aug 03
First quarter 2025 earnings released: EPS: ₹15.81 (vs ₹44.82 in 1Q 2024) First quarter 2025 results: EPS: ₹15.81 (down from ₹44.82 in 1Q 2024). Revenue: ₹8.30b (down 18% from 1Q 2024). Net income: ₹1.51b (down 65% from 1Q 2024). Profit margin: 18% (down from 42% in 1Q 2024). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 9.9% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 19% per year whereas the company’s share price has increased by 18% per year. Valuation Update With 7 Day Price Move • Aug 02
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹629, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 36x in the Chemicals industry in India. Total returns to shareholders of 108% over the past three years. Aankondiging • Jul 11
GHCL Limited to Report Q1, 2025 Results on Aug 01, 2024 GHCL Limited announced that they will report Q1, 2025 results on Aug 01, 2024 Reported Earnings • Jun 19
Full year 2024 earnings: EPS in line with expectations, revenues disappoint Full year 2024 results: EPS: ₹83.43 (down from ₹117 in FY 2023). Revenue: ₹34.5b (down 24% from FY 2023). Net income: ₹7.94b (down 29% from FY 2023). Profit margin: 23% (down from 25% in FY 2023). Revenue missed analyst estimates by 8.8%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 6.0% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth. Recent Insider Transactions • Jun 10
Board Member recently bought ₹249k worth of stock On the 4th of June, Neelabh Dalmia bought around 501 shares on-market at roughly ₹496 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth ₹497k. Despite this recent purchase, insiders have collectively sold ₹4.5m more in shares than they bought in the last 12 months. Declared Dividend • May 27
Dividend reduced to ₹12.00 Dividend of ₹12.00 is 31% lower than last year. Ex-date: 1st July 2024 Payment date: 7th August 2024 Dividend yield will be 2.3%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (14% earnings payout ratio) and cash flows (17% cash payout ratio). The dividend has increased by an average of 20% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to decline by 7.4% over the next 2 years. However, it would need to fall by 84% to increase the payout ratio to a potentially unsustainable range. New Risk • May 14
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 3.5% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 3.5% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Aankondiging • May 08
GHCL Limited, Annual General Meeting, Jul 08, 2024 GHCL Limited, Annual General Meeting, Jul 08, 2024. Reported Earnings • May 07
Full year 2024 earnings: EPS in line with expectations, revenues disappoint Full year 2024 results: EPS: ₹83.43 (down from ₹117 in FY 2023). Revenue: ₹35.0b (down 23% from FY 2023). Net income: ₹7.94b (down 29% from FY 2023). Profit margin: 23% (down from 25% in FY 2023). Revenue missed analyst estimates by 8.8%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth. Aankondiging • Apr 10
GHCL Limited to Report Q4, 2024 Results on May 06, 2024 GHCL Limited announced that they will report Q4, 2024 results on May 06, 2024 Recent Insider Transactions • Apr 02
Board Member recently bought ₹497k worth of stock On the 28th of March, Neelabh Dalmia bought around 1k shares on-market at roughly ₹451 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth ₹2.5m. Despite this recent purchase, insiders have collectively sold ₹3.8m more in shares than they bought in the last 12 months. Recent Insider Transactions • Mar 26
Insider recently bought ₹89k worth of stock On the 22nd of March, Manoj Ishwar bought around 200 shares on-market at roughly ₹443 per share. This trade did not impact their existing holding. In the last 3 months, there was an even bigger purchase from another insider worth ₹2.5m. Despite this recent purchase, insiders have collectively sold ₹4.3m more in shares than they bought in the last 12 months. Recent Insider Transactions • Mar 09
Non-Executive Chairman recently bought ₹2.5m worth of stock On the 5th of March, Anurag Dalmia bought around 5k shares on-market at roughly ₹510 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Anurag's only on-market trade for the last 12 months. Price Target Changed • Feb 22
Price target decreased by 8.6% to ₹660 Down from ₹722, the current price target is provided by 1 analyst. New target price is 29% above last closing price of ₹512. The company is forecast to post earnings per share of ₹83.20 for next year compared to ₹117 last year. Reported Earnings • Feb 04
Third quarter 2024 earnings released: EPS: ₹10.50 (vs ₹25.93 in 3Q 2023) Third quarter 2024 results: EPS: ₹10.50 (down from ₹25.93 in 3Q 2023). Revenue: ₹8.13b (down 37% from 3Q 2023). Net income: ₹998.5m (down 60% from 3Q 2023). Profit margin: 12% (down from 19% in 3Q 2023). Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 44% per year whereas the company’s share price has increased by 40% per year. Aankondiging • Jan 11
GHCL Limited to Report Q3, 2024 Results on Feb 03, 2024 GHCL Limited announced that they will report Q3, 2024 results on Feb 03, 2024 Reported Earnings • Nov 09
Second quarter 2024 earnings released: EPS: ₹15.01 (vs ₹31.46 in 2Q 2023) Second quarter 2024 results: EPS: ₹15.01 (down from ₹31.46 in 2Q 2023). Revenue: ₹8.05b (down 42% from 2Q 2023). Net income: ₹1.43b (down 53% from 2Q 2023). Profit margin: 18% (down from 22% in 2Q 2023). Revenue is forecast to grow 5.4% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 52% per year whereas the company’s share price has increased by 49% per year. Aankondiging • Oct 18
GHCL Limited to Report Q2, 2024 Results on Nov 07, 2023 GHCL Limited announced that they will report Q2, 2024 results at 12:08 PM, Indian Standard Time on Nov 07, 2023 Recent Insider Transactions • Sep 13
President & COO of Soda Ash recently sold ₹6.2m worth of stock On the 8th of September, N. Radia sold around 10k shares on-market at roughly ₹620 per share. This transaction amounted to 9.5% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹2.4m more than they bought in the last 12 months. Recent Insider Transactions • Aug 28
Chief Human Resource Officer recently sold ₹412k worth of stock On the 24th of August, Biswarup Goswami sold around 800 shares on-market at roughly ₹516 per share. This transaction amounted to 80% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth ₹1.2m. Despite this recent sale, insiders have collectively bought ₹2.2m more than they sold in the last 12 months. New Risk • Aug 11
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 20% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 20% per year for the foreseeable future. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Reported Earnings • Aug 08
First quarter 2024 earnings released: EPS: ₹44.82 (vs ₹36.72 in 1Q 2023) First quarter 2024 results: EPS: ₹44.82 (up from ₹36.72 in 1Q 2023). Revenue: ₹10.2b (down 26% from 1Q 2023). Net income: ₹4.26b (up 22% from 1Q 2023). Profit margin: 42% (up from 26% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 6.6% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 56% per year whereas the company’s share price has increased by 54% per year. Aankondiging • Jul 28
GHCL Limited to Report Q1, 2024 Results on Aug 07, 2023 GHCL Limited announced that they will report Q1, 2024 results at 12:08 PM, Indian Standard Time on Aug 07, 2023 Recent Insider Transactions • Jun 28
Vice President of Finance & Account recently sold ₹1.2m worth of stock On the 26th of June, Manish Shah sold around 2k shares on-market at roughly ₹507 per share. This transaction amounted to 55% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought ₹3.7m more than they sold in the last 12 months. Upcoming Dividend • Jun 16
Upcoming dividend of ₹17.50 per share at 3.5% yield Eligible shareholders must have bought the stock before 23 June 2023. Payment date: 31 July 2023. Payout ratio is a comfortable 15% and this is well supported by cash flows. Trailing yield: 3.5%. Within top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.9%). Buying Opportunity • Jun 12
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 4.3%. The fair value is estimated to be ₹612, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 52%. Revenue is forecast to grow by 9.5% in 2 years. Earnings is forecast to decline by 17% in the next 2 years. Reported Earnings • Jun 11
Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2023 results: EPS: ₹117 (up from ₹46.82 in FY 2022). Revenue: ₹45.5b (up 49% from FY 2022). Net income: ₹11.2b (up 150% from FY 2022). Profit margin: 25% (up from 15% in FY 2022). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 13%. Earnings per share (EPS) exceeded analyst estimates by 12%. Revenue is forecast to grow 4.5% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 52% per year whereas the company’s share price has increased by 53% per year. Recent Insider Transactions • Jun 05
Board Member recently bought ₹998k worth of stock On the 2nd of June, Neelabh Dalmia bought around 2k shares on-market at roughly ₹487 per share. This transaction amounted to 1.9% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought ₹3.3m more in shares than they have sold in the last 12 months. Reported Earnings • May 01
Full year 2023 earnings released: EPS: ₹117 (vs ₹62.81 in FY 2022) Full year 2023 results: EPS: ₹117 (up from ₹62.81 in FY 2022). Revenue: ₹45.8b (up 21% from FY 2022). Net income: ₹11.2b (up 87% from FY 2022). Profit margin: 24% (up from 16% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 1.5% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has increased by 69% per year, which means it is tracking significantly ahead of earnings growth. Price Target Changed • Feb 09
Price target decreased by 14% to ₹644 Down from ₹745, the current price target is provided by 1 analyst. New target price is 27% above last closing price of ₹506. Stock is up 10% over the past year. The company is forecast to post earnings per share of ₹107 for next year compared to ₹62.81 last year. Reported Earnings • Feb 01
Third quarter 2023 earnings released: EPS: ₹25.93 (vs ₹16.07 in 3Q 2022) Third quarter 2023 results: EPS: ₹25.93 (up from ₹16.07 in 3Q 2022). Revenue: ₹12.9b (up 28% from 3Q 2022). Net income: ₹2.48b (up 62% from 3Q 2022). Profit margin: 19% (up from 15% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 1.3% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth. Aankondiging • Jan 14
GHCL Limited to Report Q3, 2023 Results on Jan 31, 2023 GHCL Limited announced that they will report Q3, 2023 results at 12:08 PM, Indian Standard Time on Jan 31, 2023 Recent Insider Transactions • Jan 04
Insider recently bought ₹77k worth of stock On the 30th of December, Ankita Gupta bought around 150 shares on-market at roughly ₹511 per share. This transaction increased Ankita Gupta's direct individual holding by 6x at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth ₹709k. Despite this recent purchase, insiders have collectively sold ₹3.4m more in shares than they bought in the last 12 months. Recent Insider Transactions • Dec 15
Board Member recently bought ₹534k worth of stock On the 9th of December, Neelabh Dalmia bought around 1k shares on-market at roughly ₹534 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth ₹2.0m. Despite this recent purchase, insiders have collectively sold ₹5.1m more in shares than they bought in the last 12 months. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 6 highly experienced directors. Lead Independent Director Manoj Vaish was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 02
Second quarter 2023 earnings: EPS misses analyst expectations Second quarter 2023 results: EPS: ₹31.46 (up from ₹11.55 in 2Q 2022). Revenue: ₹13.9b (up 41% from 2Q 2022). Net income: ₹3.00b (up 173% from 2Q 2022). Profit margin: 22% (up from 11% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.5%. Revenue is forecast to grow 2.2% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has increased by 45% per year, which means it is tracking significantly ahead of earnings growth. Aankondiging • Oct 07
GHCL Limited to Report Q2, 2023 Results on Oct 31, 2022 GHCL Limited announced that they will report Q2, 2023 results on Oct 31, 2022 Buying Opportunity • Sep 28
Now 21% undervalued Over the last 90 days, the stock is up 13%. The fair value is estimated to be ₹808, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.9% over the last 3 years. Earnings per share has grown by 22%. Revenue is forecast to grow by 9.0% in a year. Earnings is forecast to decline by 12% in the next year. Recent Insider Transactions • Sep 24
Non-Executive Vice Chairman recently bought ₹2.0m worth of stock On the 21st of September, Anurag Dalmia bought around 3k shares on-market at roughly ₹680 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Anurag's only on-market trade for the last 12 months. Recent Insider Transactions • Sep 16
Insider recently sold ₹840k worth of stock On the 13th of September, Deepika Abrol sold around 1k shares on-market at roughly ₹700 per share. This transaction amounted to 24% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹7.9m more than they bought in the last 12 months. Buying Opportunity • Aug 19
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 3.8%. The fair value is estimated to be ₹778, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.9% over the last 3 years. Earnings per share has grown by 22%. Revenue is forecast to grow by 9.0% in a year. Earnings is forecast to decline by 12% in the next year. Recent Insider Transactions • Aug 14
Senior Vice President of Finance recently bought ₹252k worth of stock On the 10th of August, Manish Shah bought around 400 shares on-market at roughly ₹629 per share. In the last 3 months, they made an even bigger purchase worth ₹378k. Despite this recent purchase, insiders have collectively sold ₹6.4m more in shares than they bought in the last 12 months. Recent Insider Transactions • Aug 06
Senior Vice President of Finance recently bought ₹378k worth of stock On the 3rd of August, Manish Shah bought around 600 shares on-market at roughly ₹630 per share. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold ₹6.6m more in shares than they bought in the last 12 months. Buying Opportunity • Aug 02
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 3.1%. The fair value is estimated to be ₹781, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.9% over the last 3 years. Earnings per share has grown by 22%. Revenue is forecast to decline by 5.6% in a year. Earnings is forecast to decline by 22% in the next year. Reported Earnings • Jul 29
First quarter 2023 earnings released: EPS: ₹73.44 (vs ₹10.80 in 1Q 2022) First quarter 2023 results: EPS: ₹73.44 (up from ₹10.80 in 1Q 2022). Revenue: ₹13.7b (up 61% from 1Q 2022). Net income: ₹3.50b (up 242% from 1Q 2022). Profit margin: 26% (up from 12% in 1Q 2022). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 5.7% compared to a 15% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth. Aankondiging • Jul 16
GHCL Limited to Report Q1, 2023 Results on Jul 28, 2022 GHCL Limited announced that they will report Q1, 2023 results on Jul 28, 2022 Recent Insider Transactions • Jul 02
Board Member recently bought ₹899k worth of stock On the 28th of June, Neelabh Dalmia bought around 2k shares on-market at roughly ₹580 per share. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold ₹6.1m more in shares than they bought in the last 12 months. Valuation Update With 7 Day Price Move • Jun 22
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₹548, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 146% over the past three years. Recent Insider Transactions • Jun 22
Insider recently sold ₹660k worth of stock On the 16th of June, M. Sivabalasubramanian sold around 1k shares on-market at roughly ₹660 per share. In the last 3 months, they made an even bigger sale worth ₹1.9m. Insiders have been net sellers, collectively disposing of ₹7.0m more than they bought in the last 12 months. Upcoming Dividend • Jun 15
Upcoming dividend of ₹15.00 per share Eligible shareholders must have bought the stock before 22 June 2022. Payment date: 30 July 2022. Payout ratio is a comfortable 16% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of Indian dividend payers (1.8%). Higher than average of industry peers (0.8%). Board Change • Jun 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 5 highly experienced directors. Independent Director Manoj Vaish was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Recent Insider Transactions • May 26
Insider recently sold ₹1.3m worth of stock On the 20th of May, M. Sivabalasubramanian sold around 2k shares on-market at roughly ₹633 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹3.1m more than they bought in the last 12 months. Recent Insider Transactions • May 08
Insider recently sold ₹445k worth of stock On the 5th of May, M. Sivabalasubramanian sold around 679 shares on-market at roughly ₹655 per share. In the last 3 months, there was an even bigger sale from another insider worth ₹763k. Insiders have been net sellers, collectively disposing of ₹1.9m more than they bought in the last 12 months. Reported Earnings • May 04
Full year 2022 earnings: EPS and revenues exceed analyst expectations Full year 2022 results: EPS: ₹62.81 (up from ₹34.32 in FY 2021). Revenue: ₹37.8b (up 30% from FY 2021). Net income: ₹5.98b (up 84% from FY 2021). Profit margin: 16% (up from 11% in FY 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 6.3%. Earnings per share (EPS) also surpassed analyst estimates by 46%. Over the next year, revenue is forecast to stay flat compared to a 21% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 39% per year, which means it is tracking significantly ahead of earnings growth. Board Change • May 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 5 highly experienced directors. Independent Director Manoj Vaish was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Price Target Changed • Apr 27
Price target increased to ₹486 Up from ₹154, the current price target is provided by 1 analyst. New target price is 19% below last closing price of ₹601. Stock is up 155% over the past year. The company is forecast to post earnings per share of ₹46.30 for next year compared to ₹34.32 last year. Aankondiging • Apr 08
GHCL Limited to Report Fiscal Year 2022 Final Results on Apr 30, 2022 GHCL Limited announced that they will report fiscal year 2022 final results on Apr 30, 2022 Recent Insider Transactions • Apr 05
Insider recently sold ₹654k worth of stock On the 30th of March, M. Sivabalasubramanian sold around 1k shares on-market at roughly ₹542 per share. In the last 3 months, there was an even bigger sale from another insider worth ₹763k. Insiders have been net sellers, collectively disposing of ₹1.4m more than they bought in the last 12 months. Buying Opportunity • Mar 29
Now 21% undervalued Over the last 90 days, the stock is up 46%. The fair value is estimated to be ₹693, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 4.1% per annum over the last 3 years. Recent Insider Transactions • Mar 16
Insider recently sold ₹763k worth of stock On the 14th of March, Rupesh Mundhra sold around 2k shares on-market at roughly ₹509 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Valuation Update With 7 Day Price Move • Mar 11
Investor sentiment improved over the past week After last week's 16% share price gain to ₹494, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 128% over the past three years. Aankondiging • Jan 29
GHCL Limited to Report Q3, 2022 Results on Jan 27, 2022 GHCL Limited announced that they will report Q3, 2022 results on Jan 27, 2022 Reported Earnings • Jan 28
Third quarter 2022 earnings: EPS and revenues exceed analyst expectations Third quarter 2022 results: EPS: ₹16.07 (up from ₹12.37 in 3Q 2021). Revenue: ₹10.1b (up 24% from 3Q 2021). Net income: ₹1.53b (up 30% from 3Q 2021). Profit margin: 15% (in line with 3Q 2021). Revenue exceeded analyst estimates by 5.4%. Earnings per share (EPS) also surpassed analyst estimates by 32%. Over the next year, revenue is expected to shrink by 4.6% compared to a 19% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth. Buying Opportunity • Jan 24
Now 25% undervalued after recent price drop Over the last 90 days, the stock is down 4.9%. The fair value is estimated to be ₹542, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 22% over the last year. Earnings per share has grown by 60% over the last year. Reported Earnings • Nov 01
Second quarter 2022 earnings released: EPS ₹11.55 (vs ₹8.89 in 2Q 2021) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2022 results: Revenue: ₹9.83b (up 22% from 2Q 2021). Net income: ₹1.10b (up 30% from 2Q 2021). Profit margin: 11% (in line with 2Q 2021). Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improved over the past week After last week's 16% share price gain to ₹439, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 120% over the past three years. Valuation Update With 7 Day Price Move • Aug 30
Investor sentiment improved over the past week After last week's 16% share price gain to ₹375, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 57% over the past three years. Price Target Changed • Aug 23
Price target increased to ₹438 Up from ₹154, the current price target is provided by 1 analyst. New target price is 36% above last closing price of ₹323. Stock is up 87% over the past year. Aankondiging • May 24
GHCL Limited Announces Temporary Closure of Business Operations At the Yarn Division Plants At Paravai & Manaparai in Tamil Nadu GHCL Limited announced that pursuant to Regulation 30 of SEBI Regulations, 2015 read with Para B of Part A of Schedule III of said regulations, intimation be and is hereby given that as per the direction of Govt. of Tamil Nadu vide their Notification G.O. (Ms) No. 386 dated May 22, 2021 issued by department of Revenue and Disaster Management (DM-IV) the company has taken a decision for temporary closure of its Yarn Division located in Paravai & Manaparai from 4.00 A.M on May 24, 2021 till 6.00 A.M. on May 31, 2021 As per the current situation, business operations at said plants of Yarn division will be commenced on May 31, 2021 after 6.00 A.M. as usual. In order to ensure health and safety of the company's employees advised has also been issued to follow Covid-19 protocol and maintain social distancing, adequate sanitisation and masking. Reported Earnings • May 02
Full year 2021 earnings released: EPS ₹34.32 (vs ₹40.51 in FY 2020) The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2021 results: Revenue: ₹29.3b (down 11% from FY 2020). Net income: ₹3.26b (down 18% from FY 2020). Profit margin: 11% (in line with FY 2020). Over the last 3 years on average, earnings per share has fallen by 7% per year whereas the company’s share price has fallen by 5% per year. Aankondiging • Apr 29
GHCL Limited Recommends Dividend for the Financial Year Ended March 31, 2021, Payable on or After June 23, 2021 GHCL Limited announced that at its board meeting held on April 28, 2021, it has recommended Dividend of INR 5.50 per share (i.e.55 % on paid up capital) for the financial year ended March 31, 2021. Dividend will be paid on or after June 23, 2021,if approved by the members in the upcoming Annual General Meeting. Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment improved over the past week After last week's 17% share price gain to ₹253, the stock is trading at a trailing P/E ratio of 7.9x, up from the previous P/E ratio of 6.7x. This compares to an average P/E of 17x in the Chemicals industry in India. Total returns to shareholders over the past three years were flat. Recent Insider Transactions • Mar 03
Insider recently sold ₹253k worth of stock On the 23rd of February, Pavuluru Rao sold around 1k shares on-market at roughly ₹217 per share. In the last 3 months, there was an even bigger sale from another insider worth ₹2.2m. Insiders have been net sellers, collectively disposing of ₹764k more than they bought in the last 12 months.